Medical specialists from Canada tagged as investigators in clinical trials studying Respiratory Syncytial Virus Infections

Total 15 results

Anthony Bier
Seen in:
- Ontario, Guelph, GSK Investigational Site
Trials:
- NCT06389487 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Bonavuth Pek
Seen in:
- Quebec, St-Charles-Borromée, GSK Investigational Site
Trials:
- NCT05590403 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Celine Bergeron
Seen in:
- British Columbia, Vancouver, GSK Investigational Site
- British Columbia, Vancouver, University of British Columbia
Trials:
- NCT04045587 (Principal Investigator)
- NCT05921903 (Principal Investigator)
Conditions:
- Severe Asthma;
- Respiratory Syncytial Virus Infections
Daniel Fantus
Seen in:
- Quebec, Montreal, GSK Investigational Site
Trials:
- NCT05921903 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
David Shu
Seen in:
- British Colombia, New Westminster, Office of David H. Shu, MD
- British Columbia, New Westminster, GSK Investigational Site
Trials:
- NCT05590403 (Principal Investigator)
- NCT05838755 (Principal Investigator)
- NCT05891834 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
Deepali Kumar
Seen in:
- Ontario, Toronto, GSK Investigational Site
Trials:
- NCT05921903 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Jean-Francois Roussy
Seen in:
- Quebec, GSK Investigational Site
Trials:
- NCT06389487 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Jean-Sebastien Gauthier
Seen in:
- Quebec, Sherbrooke, GSK Investigational Site
Trials:
- NCT05921903 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Karen Doucette
Seen in:
- Alberta, Edmonton, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05921903 (Principal Investigator)
Conditions:
Marie-Louise Vachon
Seen in:
- Québec, GSK Investigational Site
Trials:
- NCT06214052 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
- HIV Infections;
- Respiratory Syncytial Virus Infections
Michael B Jones
Seen in:
- British Columbia, Victoria, GSK Investigational Site
Trials:
- NCT05838742 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
- Pain;
- Respiratory Syncytial Virus Infections
Murdo Ferguson
Seen in:
- Nova Scotia, Truro, GSK Investigational Site
- Truro, GSK Investigational Site
Trials:
- NCT05823974 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
- Influenza, Human;
- Respiratory Syncytial Virus Infections
Peter Dzongowski
Seen in:
- Ontario, London, GSK Investigational Site
- Ontario, London, Milestone Research Inc
- Ontario, London, Milestone Research Inc.
Trials:
- NCT05590403 (Principal Investigator)
- NCT05838742 (Principal Investigator)
- NCT05882045 (Principal Investigator)
- NCT05891834 (Principal Investigator)
- NCT06389487 (Principal Investigator)
Conditions:
Sarah Shalhoub
Seen in:
- London, University Hospital - London Health Sciences Centre
- Ontario, London, GSK Investigational Site
Trials:
- NCT04669015 (Principal Investigator)
- NCT05921903 (Principal Investigator)
Conditions:
- Covid19;
- Respiratory Syncytial Virus Infections
Ying Tung Sia
Seen in:
- Quebec, Trois-Rivieres, Diex Recherche Trois-Rivieres
- Quebec, Trois-Rivieres, GSK Investigational Site
Trials:
- NCT05590403 (Principal Investigator)
- NCT06292013 (Principal Investigator)
Conditions:

Clinical Trials on Respiratory Syncytial Virus Infections

Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Respiratory Syncytial Virus Immunization

United States, Australia, Puerto Rico
EuBiologics Co.,Ltd

Recruiting

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years (EuRSV)

Respiratory Syncytial Virus Infections | Respiratory Syncytial Virus (RSV)

Korea, Republic of
Clover Biopharmaceuticals AUS Pty Ltd

Recruiting

First-in-human Safety and Immunogenicity Study of SCB-1019 in Healthy Adults

Respiratory Syncytial Virus Infection

Australia
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

Respiratory Syncytial Virus Infection

United States, Puerto Rico
Pfizer

Completed

A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.

Respiratory Syncytial Virus Infection

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (VAD00001)

Respiratory Syncytial Virus Infection

Honduras, United States, Chile
AbbVie (prior sponsor, Abbott)

Completed

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

Respiratory Syncytial Virus Infection

Japan
Vigonvita Life Sciences

Recruiting

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Respiratory Syncytial Virus Infection

China
AbbVie (prior sponsor, Abbott)

Completed

Surveillance of Synagis in Korean Pediatric Patients

Respiratory Syncytial Virus Infection
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biosciences Pty Ltd.

Completed

Viral Inhibition in Children for Treatment of RSV (VICTOR)

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Australia, Hong Kong, Israel, Lebanon, Malaysia, Poland, Taiwan, Turkey

Medical specialists from Canada tagged as investigators in clinical trials studying Respiratory Syncytial Virus Infections

Clinical Trials on Respiratory Syncytial Virus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations